Patent 7803527 was granted and assigned to Novartis on September, 2010 by the United States Patent and Trademark Office.
This invention related to a method of immunizing cattle to reduce the effects of infection by bovine herpes virus 1, including abortion and stillbirth, by administering inactivated bovine herpes virus 1 prior to breeding.